Literature DB >> 25502380

Ligand biological activity predictions using fingerprint-based artificial neural networks (FANN-QSAR).

Kyaw Z Myint1, Xiang-Qun Xie.   

Abstract

This chapter focuses on the fingerprint-based artificial neural networks QSAR (FANN-QSAR) approach to predict biological activities of structurally diverse compounds. Three types of fingerprints, namely ECFP6, FP2, and MACCS, were used as inputs to train the FANN-QSAR models. The results were benchmarked against known 2D and 3D QSAR methods, and the derived models were used to predict cannabinoid (CB) ligand binding activities as a case study. In addition, the FANN-QSAR model was used as a virtual screening tool to search a large NCI compound database for lead cannabinoid compounds. We discovered several compounds with good CB2 binding affinities ranging from 6.70 nM to 3.75 μM. The studies proved that the FANN-QSAR method is a useful approach to predict bioactivities or properties of ligands and to find novel lead compounds for drug discovery research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25502380      PMCID: PMC4510302          DOI: 10.1007/978-1-4939-2239-0_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  53 in total

1.  A neural network based virtual screening of cytochrome P450 3A4 inhibitors.

Authors:  László Molnar; György M Keseru
Journal:  Bioorg Med Chem Lett       Date:  2002-02-11       Impact factor: 2.823

2.  Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis.

Authors:  P Chavatte; S Yous; C Marot; N Baurin; D Lesieur
Journal:  J Med Chem       Date:  2001-09-27       Impact factor: 7.446

3.  On the use of neural network ensembles in QSAR and QSPR.

Authors:  Dimitris K Agrafiotis; Walter Cedeño; Victor S Lobanov
Journal:  J Chem Inf Comput Sci       Date:  2002 Jul-Aug

4.  Reoptimization of MDL keys for use in drug discovery.

Authors:  Joseph L Durant; Burton A Leland; Douglas R Henry; James G Nourse
Journal:  J Chem Inf Comput Sci       Date:  2002 Nov-Dec

Review 5.  Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology.

Authors:  Roger Perkins; Hong Fang; Weida Tong; William J Welsh
Journal:  Environ Toxicol Chem       Date:  2003-08       Impact factor: 3.742

6.  Design, synthesis, computational prediction, and biological evaluation of ester soft drugs as inhibitors of dihydrofolate reductase from Pneumocystis carinii.

Authors:  M Graffner-Nordberg; K Kolmodin; J Aqvist; S F Queener; A Hallberg
Journal:  J Med Chem       Date:  2001-07-19       Impact factor: 7.446

7.  Structure-based design of selective inhibitors of dihydrofolate reductase: synthesis and antiparasitic activity of 2, 4-diaminopteridine analogues with a bridged diarylamine side chain.

Authors:  A Rosowsky; V Cody; N Galitsky; H Fu; A T Papoulis; S F Queener
Journal:  J Med Chem       Date:  1999-11-18       Impact factor: 7.446

8.  Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents.

Authors:  I K Khanna; Y Yu; R M Huff; R M Weier; X Xu; F J Koszyk; P W Collins; J N Cogburn; P C Isakson; C M Koboldt; J L Masferrer; W E Perkins; K Seibert; A W Veenhuizen; J Yuan; D C Yang; Y Y Zhang
Journal:  J Med Chem       Date:  2000-08-10       Impact factor: 7.446

9.  Prediction of tumoricidal activity and accumulation of photosensitizers in photodynamic therapy using multiple linear regression and artificial neural networks.

Authors:  R Vanyrúr; K Héberger; I Kövesdi; J Jakus
Journal:  Photochem Photobiol       Date:  2002-05       Impact factor: 3.421

10.  4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2.

Authors:  J J Talley; D L Brown; J S Carter; M J Graneto; C M Koboldt; J L Masferrer; W E Perkins; R S Rogers; A F Shaffer; Y Y Zhang; B S Zweifel; K Seibert
Journal:  J Med Chem       Date:  2000-03-09       Impact factor: 7.446

View more
  3 in total

1.  Development and Testing of Druglike Screening Libraries.

Authors:  Junmei Wang; Yubin Ge; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2019-01-03       Impact factor: 4.956

Review 2.  Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era.

Authors:  Yankang Jing; Yuemin Bian; Ziheng Hu; Lirong Wang; Xiang-Qun Xie
Journal:  AAPS J       Date:  2018-03-30       Impact factor: 4.009

Review 3.  Machine Learning Based Toxicity Prediction: From Chemical Structural Description to Transcriptome Analysis.

Authors:  Yunyi Wu; Guanyu Wang
Journal:  Int J Mol Sci       Date:  2018-08-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.